And the follow-up study: https://www.sciencedirect.com/science/article/pii/S2589537024000543 https://www.sciencedirect.com/science/article/pii/S258953702... Th

And the follow-up study: https://www.sciencedirect.com/science/article/pii/S2589537024000543 https://www.sciencedirect.com/science/article/pii/S258953702... The conclusion to the follow-up study might have a clue to (1.): > The addition of supervised exercise to obesity pharmacotherapy seems to improve healthy weight maintenance after treatment termination compared with treatment termination of obesity pharmacotherapy alone. Ozempic in the title could be a stand-in for "obesity pharmacotherapy" and maybe they chose the more recognizable brand name. It's also not very surprising that those in the supervised exercise group were better off a year later, they'd developed a healthy habit.